Earnings Feed
Start Free
Home/Filings/4/0000864268-03-000103
4//SEC Filing

BRADLEY PHARMACEUTICALS INC 4

Accession 0000864268-03-000103

CIK 0000864268operating
View on SEC.govCompany Profile

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 3:02 PM ET

Size

6.9 KB

Accession

0000864268-03-000103

Insider Transaction Report

Form 4
Period: 2003-10-20
BRADLEY PHARMACEUTICALS INCBDY
BHAGWAT DILEEP
VP - Research and Development
Transactions
  • Discretionary Transaction

    Common Stock

    2003-10-20$26.35/sh+22$580→ 22 total(indirect: By 401(k))
Holdings

  • Stock Options (Right to buy)

    Exercise: $1.09From: 2002-09-07Exp: 2009-09-06→ Common Stock (8,000 underlying)
    8,000

  • Stock Options (Right to buy)

    Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (753 underlying)
    753

  • Common Stock

    (indirect: By 401(k))
    1,501

  • Common Stock

    (indirect: By IRA)
    1,000

  • Common Stock

    2,226

Documents

1 file

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000864268

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 3:02 PM ET
Size
6.9 KB
View on SEC.gov